JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma

Overview of attention for article published in Science, June 2024

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

news: 15 news outlets
blogs: 2 blogs
twitter: 73 X users

facebook: 3 Facebook pages
wikipedia: 1 Wikipedia page
reddit: 2 Redditors

Readers on

mendeley: 119 Mendeley

So far, Altmetric has seen 16 news stories from 15 outlets.

Una combinación de medicamentos con inhibidores de JAK mejoró la inmunoterapia en dos estudios clínicos

National Cancer Institute, 01 Oct 2024

1 de Octubre de 2024, por Nadia Jaber Las proteínas JAK (en azul), adonde se dirigen los inhibidores de JAK, controlan las…

JAK Inhibitors Boost Immunotherapy in Clinical Trials

National Cancer Institute, 08 Aug 2024

August 8, 2024, by Nadia Jaber JAK proteins (blue)—the targets of JAK inhibitors—are like puppet masters, pulling the strings…

JAK inhibition enhances immunotherapy in Hodgkin lymphoma

Thelimbic, 30 Jun 2024

Adding a JAK inhibitor to checkpoint immunotherapy in blood cancer patients may counter the negative effects of prolonged…

New Strategy to Enhance Checkpoint Inhibitor Therapy for Cancer

Medindia, 27 Jun 2024

Checkpoint inhibitor therapies release the immune system's molecular "brakes," removing protein barriers that hinder its…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 12 additional news stories.